![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
20
S.i.m.s. S.r.l. Reggello It, based in Italy, is a pharmaceutical company that stands out with its certifications from FDA.
One of their significant offerings is Mepivacaine hydrochloride, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2010-129 - Rev 02
This Chemical Type CEP, issued on August 01, 2019, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1242 associated with this CEP further emphasizes